Free Trial

Amplifon (OTCMKTS:AMFPF) Shares Up 5% - Here's Why

Amplifon logo with Medical background

Key Points

  • Amplifon S.p.A. shares rose by 5% during mid-day trading, reaching a high of $18.33 with significant trading volume, an increase of 2,612% compared to the average session.
  • Morgan Stanley has reiterated an "overweight" rating on Amplifon, signaling positive confidence among analysts with a consensus rating of "Moderate Buy."
  • In its latest earnings report, Amplifon reported $0.25 earnings per share, which was below analysts’ expectations of $0.34, although its revenue of $698.20 million exceeded estimates.
  • Five stocks we like better than Amplifon.

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report) shot up 5% during mid-day trading on Tuesday . The stock traded as high as $18.33 and last traded at $18.33. 160 shares changed hands during trading, an increase of 2,612% from the average session volume of 6 shares. The stock had previously closed at $17.46.

Wall Street Analyst Weigh In

Separately, Morgan Stanley reiterated an "overweight" rating on shares of Amplifon in a research report on Wednesday, June 25th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy".

Read Our Latest Stock Analysis on Amplifon

Amplifon Price Performance

The company has a debt-to-equity ratio of 1.03, a current ratio of 0.61 and a quick ratio of 0.53. The stock has a market cap of $4.13 billion, a price-to-earnings ratio of 30.05 and a beta of 0.35. The business's 50-day simple moving average is $19.98 and its two-hundred day simple moving average is $21.40.

Amplifon (OTCMKTS:AMFPF - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.25 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.09). The company had revenue of $698.20 million during the quarter, compared to analyst estimates of $625.73 million. Amplifon had a net margin of 5.20% and a return on equity of 13.70%.

Amplifon Company Profile

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.